Dose Duration Optimization LIFU

Recruiting
99 years or below
All
Phase N/A
20 participants needed
1 Location

Brief description of study

Obsessive-compulsive disorder (OCD) is a serious mental health condition that affects approximately 2.2 million adults in the United States. People with OCD experience unwanted, intrusive thoughts (obsessions) and feel compelled to perform repetitive behaviors (compulsions). This study is a randomized, sham-controlled trial evaluating the safety, tolerability, and target engagement of multi-session subthalamic nucleus (STN)-targeted low-intensity focused ultrasound (LIFU) in adults with OCD. Twenty participants will be randomized to receive either active or sham LIFU delivered via the ATTN201 wearable device (Attune Neurosciences) twice weekly over up to 8 sessions. All participants will undergo MRI at baseline and at three checkpoints. The study will evaluate two treatment course durations (4 sessions and 8 sessions of LIFU).

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: Medical Research
  • Age: 99 years or below
  • Gender: All

TBD

Updated on 15 Sep 2026. Study ID: 26-7004

Find a site

We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team


Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Preferred way of contact
Please provide your preferred way of contact
Other language

Interested in the study

Select a study center that’s convenient for you, and get in touch with the study team.

Contact a study center